As Covid-19 started to spread across China in early 2020, Noubar Afeyan, chair of Moderna, received a telephone call. It was his chief executive telling him that senior public health officials had asked if the biotech’s experimental vaccine delivery technology could help fight the virus.
2020年初，隨著新冠疫情在中國蔓延，摩德納董事長努巴·阿費揚(Noubar Afeyan)接到了一個電話。他的首席執行官告訴他，高級公共衛生官員詢問這家生物技術公司的實驗性疫苗開發技術是否有助于抗擊病毒。
您已閱讀3%（391字），剩余97%（12027字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。